Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer

被引：0
作者：
Jian Chen
Tianchuan Zhu
Guanmin Jiang
Qi Zeng
Zhijian Li
Xi Huang
机构：
[1] The Fifth Affiliated Hospital of Sun Yat-sen University,Center for Infection and Immunity and Guangdong Provincial Engineering Research Center of Molecular Imaging
[2] The Fifth Affiliated Hospital of Sun Yat-sen University,Department of Clinical Laboratory
[3] The Fifth Affiliated Hospital of Sun Yat-sen University,Department of Oncology
[4] The Fourth People’s Hospital of Foshan,undefined
来源：
Molecular Cancer | / 22卷
关键词：
CAR-T; TREM2; PD-1; Colorectal cancer; Tumor microenvironment; Single-chain variable fragment (scFv);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 349 条
[1]  
Ciardiello F(2022)Clinical management of metastatic colorectal cancer in the era of precision medicine CA Cancer J Clin 72 372-401
[2]  
Ciardiello D(2022)Cancer statistics, 2022 CA Cancer J Clin 72 7-33
[3]  
Martini G(2019)Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies Nat reviews Gastroenterol Hepatol 16 713-32
[4]  
Napolitano S(2022)Colorectal cancer immunotherapy-recent progress and future directions Cancer Lett 545 215816-218
[5]  
Tabernero J(2019)Approaches to treat immune hot, altered and cold tumours with combination immunotherapies Nat Rev Drug Discov 18 197-51
[6]  
Cervantes A(2018)The application of CAR-T cell therapy in hematological malignancies: advantages and challenges Acta Pharm Sin B 8 539-53
[7]  
Siegel RL(2019)A safe and potent anti-CD19 CAR T cell therapy Nat Med 25 947-58
[8]  
Miller KD(2017)Phase I escalating-dose trial of CAR-T therapy targeting CEA(+) metastatic colorectal cancers Mol Ther 25 1248-24
[9]  
Fuchs HE(2019)Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies J Hematol Oncol 12 59-8
[10]  
Jemal A(2017)CAR T cells administered in combination with lymphodepletion and PD-1 inhibition to patients with Neuroblastoma Mol Ther 25 2214-42
12345678910